SCHEMBL16237487

SCHEMBL16237487

O=C(O)c1c(CBr)nc(-c2nccs2)nc1-c1ccc(F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
EIF4E P06730 7/20 0.39
CDC7 O00311 1/20 0.37
DBF4 Q9UBU7 1/20 0.37
TRPM4 Q8TD43 1/20 0.34
ADORA2A P29274 1/20 0.33
F2RL1 P55085 1/20 0.33
HTR5A P47898 1/20 0.33
DHODH Q02127 1/20 0.33
KDM6B O15054 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16237522 0.89 HDAC3 (0.36) HDAC3HDAC1HDAC6ADORA2AF2RL1
SCHEMBL15516071 0.89 HDAC3 (0.41) HDAC3HDAC1HDAC6EIF4ECDC7
SCHEMBL17064231 0.86 KMT2A (0.40) HDAC3HDAC1HDAC6TRPM4ADORA2A
SCHEMBL19259491 0.85 HDAC3 (0.43) HDAC3HDAC1HDAC6EIF4ECDC7
SCHEMBL16237698 0.84 ADORA2A (0.33) HDAC3HDAC1HDAC6EIF4EADORA2A
SCHEMBL15573819 0.84 EIF4E (0.39) HDAC3HDAC1HDAC6EIF4ECDC7
SCHEMBL16237622 0.82 KMO (0.41) EIF4ETRPM4ADORA2A
SCHEMBL16237173 0.82 CTSA (0.41) HDAC3HDAC1HDAC6EIF4ETRPM4
SCHEMBL16236965 0.81 HDAC3 (0.37) HDAC3HDAC1HDAC6EIF4ECDC7
SCHEMBL16237062 0.80 ECE1 (0.34) EIF4EADORA2ADHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3732177-A1 DIHYDROPYRIMIDINYLTHIAZOLE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2020-11-04 EP disclosed
EP-3416966-A1 PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID H. Hoffnabb-La Roche Ag (CH) 2018-12-26 EP disclosed
WO-2017140750-A1 PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
EP-2997032-A1 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2016-03-23 EP disclosed
WO-2014184328-A1 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-11-20 WO disclosed